0 оценок0% нашли этот документ полезным (0 голосов)
26 просмотров7 страниц
The population of australia in 2013 was 23. Million, having grown at a CAGR of 1.6% from 2008. In 2013, the government spent $1 billion on R&D on medical and health science. The pharmaceutical market in australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020.
The population of australia in 2013 was 23. Million, having grown at a CAGR of 1.6% from 2008. In 2013, the government spent $1 billion on R&D on medical and health science. The pharmaceutical market in australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020.
The population of australia in 2013 was 23. Million, having grown at a CAGR of 1.6% from 2008. In 2013, the government spent $1 billion on R&D on medical and health science. The pharmaceutical market in australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020.
org adds report CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape Australia to its store.
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Australia. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.
The population of Australia in 2013 was 23.2 million, having grown at a CAGR of 1.6% from 2008. Medicare is Australias public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.
Complete report available @ http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and- reimbursement-landscape-australia.html .
In 2013, the government spent $1 billion on R&D on medical and health science and exported $3.8 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 5.1%. The medical device market was valued at $5.9 billion in 2008 and is projected to grow at a CAGR of 4.9% to $10.4 billion by 2020. These positive growth trends can be primarily attributed to
An increasingly elderly population Universal health coverage Government initiatives
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes:-
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, AstraZeneca, Novartis, Sanofi and Alphapharm; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Medtronic, DePuy companies and F.Hoffmann-La Roche An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices Detailed analysis of the countrys political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure An overview of the opportunities for and challenges to growth in the Australian healthcare market
Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9989 . (This is a premium report priced at US$1995 for a single user PDF.)
Reasons to buy
This report will enhance your decision-making capability by allowing you to:-
Develop business strategies by understanding the trends shaping and driving Australias healthcare market Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Australias healthcare market in the future Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships Identify, understand, and capitalize on the opportunities and challenges in Australias healthcare market
1.1 List of Tables
Table 1: Pharmaceutical Market, Australia, Revenue* ($bn), 2008-2013 21 Table 2: Pharmaceutical Market, Australia, Revenue* Forecast ($bn), 2014-2020 22 Table 3: Pharmaceutical Market, Australia, Exports and Imports ($bn), 2008-2013 23 Table 4: Pharmaceutical Market, Australia, Pharmacy and Wholesale Mark-up (%), 2014 25 Table 5: Pharmaceutical Market, Australia, Biotechnology Companies, Market Capitalization ($m), Q4 2013 27 Table 6: Pharmaceutical Market, Australia, Over-the-Counter Drugs Market ($bn), 2008-2013 28 Table 7: Pharmaceutical Market, Australia, Top Five Therapeutic Areas, Pharmaceutical Expenditure ($bn), 2013 30 Table 8: Pharmaceutical Market, Australia, Major Suppliers to PBS, Revenue ($m), 2013 32 Table 9: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 34 Table 10: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014* 35 Table 11: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue ($bn) and Annual Growth (%), 2013 43 Table 12: Pharmaceutical Market, AstraZeneca, Global, Late-stage Pipeline, 2014 44 Table 13: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 51 Table 14: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018* 52 Table 15: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013 62 Table 16: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2014* 63 Table 17: Pharmaceutical Market, Alphapharm, Global, Major Products,2013 67 Table 18: Medical Device Market, Australia, Revenue ($bn), 2008-2013 71 Table 19: Medical Device Market, Australia, Revenue Forecast ($bn), 2014-2020 72 Table 20: Medical Device Market, Australia, Revenue by Segment, 2013 73 Table 21: Medical Device Market, Australia, IVD Devices Market, Revenue ($m), 2008-2013 75 Table 22: Medical Device Market, Australia, IVD Devices Market, Sales Trends for Major Players, 2012 76 Table 23: Medical Device Market, Australia, Orthopedics Devices Market ($m), 2008-2013 77 Table 24: Medical Device Market, Australia, Orthopedics Devices Market, Sales Trends for Major Players, 2008-2012 78 Table 25: Medical Device Market, Australia, Ophthalmic Devices Market, Revenue ($m), 2008-2013 80 Table 26: Medical Device Market, Australia, Ophthalmic Devices Market, Sales Trends for Major Players, 2012 81 Table 27: Medical Device Market, Australia, Cardiovascular Devices Market, Revenue ($m), 2008-2013 82 Table 28: Medical Device Market, Australia, Cardiovascular Devices Market, Sales Trends for Major Players, 2008-2012 83 Table 29: Medical Device Market, Australia, Diagnostic Imaging Market, Sales Trends for Major Players, 2012 86 Table 30: Medical Device Market, Australia, Diagnostic Market, Revenue ($bn), 2008-2013 88 Table 31: Medical Device Market, Australia, Diagnostic Market, Revenue Forecast ($bn), 2014-2020 88 Table 32: Medical Device Market, Australia, Major Medical Device Companies Revenue, 2012 89 Table 33: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2013 105 Table 34: Medical Device Market, F. Hoffmann-La Roche, Global, Major Products, 2014 119 Table 35: Market Access, Australia, Private Health Insurance Rate (%), 2014 137 Table 36: Market Access, Australia, Private Insurance Coverage (million), 2008-2013 138 Table 37: Healthcare Spending, Australia, Out-of-Pocket Expenditure (%), 2008-2013 139 Table 38: Market Access, Australia, Average Price of Healthcare Services (%), 2008-2013 140 Table 39: Market Access, Australia, Classification of Medical Devices,, 2013 149 Table 40: Market Access, Australia, Trademark Fees by E-services, 2014 159 Table 41: Market Access, Australia, Trademark Fees by Other Means, 2014 160 Table 42: Market Access, Australia, Regulation of Advertising of Therapeutic Goods, Australia, 2013 163 Table 43: Economic Indicators, Australia, Gross Domestic Product per Capita ($), 2008-2013 175 Table 44: Economic Indicators, Australia, Gross Domestic Product per Capita ($), Forecast, 2014-2020 175 Table 45: Economic Indicators, Australia, Gross Domestic Product Annual Growth (%), 2008-2013 176 Table 46: Economic Indicators, Australia, Gross Domestic Product Annual Growth Forecast (%), 2014- 2020 177 Table 47: Economic Indicators, Australia, Gross National Income per Capita ($), 2008-2013 178 Table 48: Economic Indicators, Australia, Average Consumer Price Index, 2008-2013 180 Table 49: Economic Indicators, Australia, Average Consumer Price Index Forecast, 2014-2020 181 Table 50: Economic Indicators, Australia, Average Consumer Price, Annual Change (%), 2008-2013 182 Table 51: Economic Indicators, Australia, Currency Exchange Rate (AUD/$), 2008-2013 183 Table 52: Economic Indicators, Australia, Foreign Direct Investment ($bn), 2008-2013 184 Table 53: Economic Indicators, Australia, Foreign Exchange Reserves ($bn), 2008-2013 185 Table 54: Economic Indicators, Australia, Imports of Goods and Services ($bn), 2008-2013 187 Table 55: Economic Indicators, Australia, Exports of Goods and Services ($bn), 2008-2013 188 Table 56: Economic Indicators, Australia, General Government Structural Balance ($bn),2008-2013 189 Table 57: Economic Indicators, Australia, General Government Net Debt ($bn), 2008-2013 190 Table 58: Economic Indicators, Australia, Major Industries, Gross Value Added (%), 2012-2013 192 Table 59: Demographics, Australia, Population (million), 2008-2013 193 Table 60: Demographics, Australia, Population Forecast (million), 2014-2020 194 Table 61: Demographics, Australia, Population, Urban and Rural Population Share (%), 2008-2013 196 Table 62: Demographics, Australia, Population, Urban and Rural Population Share Forecast (%), 2014- 2020 197 Table 63: Demographics, Australia, Population Distribution by Age Group (%), 2008-2013 198 Table 64: Demographics, Australia, Population Distribution by Age Group Forecast (%), 2014-2020 199 Table 65: Demographics, Australia, Births (per 1,000 Population), 2008-2013 200 Table 66: Demographics, Australia, Mortality (per 1,000 Population), 2008-2013 201 Table 67: Demographics, Australia, Major Causes of Mortality, 2012 203 Table 68: Demographics, Australia, Children ?5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 204 Table 69: Demographics, Australia, Immunization Rate (%), 2008-2013 205 Table 70: Demographics, Australia, Major Causes of Male Mortality (000), 2012 207 Table 71: Demographics, Australia, Major Causes of Female Mortality (000), 2012 208 Table 72: Demographics, Australia, Gender Ratio (M/F), 2008-2013 209 Table 73: Demographics, Australia, Life Expectancy at Birth (Years), 2008-2013 211 Table 74: Demographics, Australia, Student Enrollment by Level of Education (% of Gross), 2008-2013 213 Table 75: Demographics, Australia, Overseas Students (%), 2008-2013 215 Table 76: Demographics, Australia, Unemployment Rate (%), 2008-2013 216 Table 77: Demographics, Australia, Major Causes of Hospitalization, 2012-2013 218 Table 78: Demographics, Australia, Major Diseases, DALYs (per 100,000 Population), 2004 219 Table 79: Healthcare Infrastructure, Australia, Hospitals, 2008-2013 220 Table 80: Healthcare Infrastructure, Australia, Public and Private Hospitals, 2008-2013 222 Table 81: Healthcare Infrastructure, Australia, Public Acute Care Hospitals, 2008-2013 223 Table 82: Healthcare Infrastructure, Australia, Public Psychiatric Hospitals, 2008-2013 224 Table 83: Healthcare Infrastructure, Australia, Private Free-standing Day Hospitals, 2008-2013 225 Table 84: Healthcare Infrastructure, Australia, Other Private Hospitals, 2008-2013 225 Table 85: Healthcare Infrastructure, Australia, Diagnostic Equipment (per Million Population), 2008-2013 226 Table 86: Healthcare Infrastructure, Australia, Total Hospital Beds (per 1,000 Population), 2008-2013 228 Table 87: Healthcare Infrastructure, Australia, Public Hospital Beds (per 1,000 Population), 2008-2013 228 Table 88: Healthcare Infrastructure, Australia, Private Hospital Beds (per 1,000 Population), 2008-2013 229 Table 89: Healthcare Infrastructure, Australia, Doctors (per 100,000 Population), 2008-2013 230 Table 90: Healthcare Infrastructure, Australia, PM10 (g/m3), 2008-2013 232 Table 91: Healthcare Infrastructure, Australia, CO2 Emissions (Million Metric Tons), 2008-2013 234 Table 92: Healthcare Infrastructure, Australia, Nurses (per 1,000 Population), 2008-2013 235 Table 93: Healthcare Infrastructure, Australia, Pharmacists (per 1,000 Population), 2008-2013 236 Table 94: Healthcare Infrastructure, Australia, Dentists (per 1,000 Population), 2008-2013 237 Table 95: Healthcare Expenditure, Australia, Healthcare Expenditure (% of GDP), 2008-2013 239 Table 96: Healthcare Expenditure, Australia, Healthcare Expenditure, Share of Major Components (%), 2012 240 Table 97: Healthcare Expenditure, Australia, Healthcare Expenditure, Public-Private Share (%), 2008- 2013 241 Table 98: Healthcare Expenditure, Australia, Research and Development Expenditure in Medical and Health Sciences ($m), 2008-2013 242
Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9989 .
About Us: MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.